← Evidence map

ReviewOncogene2020

ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics.

Nicolas Kiavue et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

70 papers cite itlatest 60 shown

2020
…
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31519989